Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, April 26, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
CytoDyn Files Request With FDA for Priority Review of BLA for First Approval
admin
-
June 1, 2020
0
Latest Pharma-News
Libtayo® longer-term results presented at ASCO 2020 in advanced cutaneous squamous cell carcinoma
admin
-
May 30, 2020
0
Latest Pharma-News
CHMP recommends EU approval of Roche’s Rozlytrek
admin
-
May 30, 2020
0
Latest Pharma-News
Pfizer’s update on phase 3 Pallas Trial of Ibrance® in HR+, HER2- early Breast Cancer
admin
-
May 30, 2020
0
Latest Pharma-News
XTANDI® extends overall survival in men with non-metastatic castration-resistant prostate cancer
admin
-
May 30, 2020
0
Latest Pharma-News
Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients
admin
-
May 30, 2020
0
Latest Pharma-News
Novartis Piqray® receives positive CHMP opinion to treat HR+/HER2- advanced breast cancer with a PIK3CA mutation
admin
-
May 30, 2020
0
Latest Pharma-News
FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids
admin
-
May 29, 2020
0
Latest Pharma-News
FDA OK’s TAUVID™ for Use in Patients Evaluated for Alzheimer’s Disease
admin
-
May 29, 2020
0
Latest Pharma-News
GSK to produce1 billion doses of pandemic vaccine adjuvant
admin
-
May 29, 2020
0
Latest Pharma-News
Tagrisso demonstrated unprecedented disease-free survival in lung cancer
admin
-
May 29, 2020
0
Latest Pharma-News
Roche’s Alecensa increases the overall survival rate for people with ALK-positive non-small cell lung cancer
admin
-
May 29, 2020
0
1
...
105
106
107
...
144
Page 106 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024